IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome

Saved in:
Bibliographic Details
Published inLeukemia Vol. 30; no. 1; pp. 255 - 258
Main Authors Landberg, N, Hansen, N, Askmyr, M, Ågerstam, H, Lassen, C, Rissler, M, Hjorth-Hansen, H, Mustjoki, S, Järås, M, Richter, J, Fioretos, T
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.01.2016
Nature Publishing Group
Subjects
13/1
13/31
14/32
631/67/1990/283/1896
ADP-ribosyl Cyclase 1 - analysis
Antigens, CD34 - analysis
Cancer Research
Care and treatment
Chronic myeloid leukemia
Clinical Medicine
Complications and side effects
Critical Care Medicine
Development and progression
Fusion Proteins, bcr-abl - analysis
Hematologi
Hematology
Humans
Intensive
Interleukin-1 Receptor Accessory Protein - analysis
Internal Medicine
Klinisk medicin
letter-to-the-editor
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology
Medical and Health Sciences
Medicin och hälsovetenskap
Medicine
Medicine & Public Health
Neoplastic Stem Cells - chemistry
Oncology
Patient outcomes
Protein-Tyrosine Kinases - antagonists & inhibitors
Stem cells
Transplantation
Treatment Outcome
Sweden
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0887-6924
1476-5551
1476-5551
DOI:10.1038/leu.2015.135